Press Release: Dupixent® (dupilumab) recommended for EU approval by the CHMP for the treatment of prurigo nodularis

Nitesh sinha November 11, 2022
https://ift.tt/QFJdzch

Dupixent® (dupilumab) recommended for EU approval by the CHMP for the treatment of prurigo nodularis



from Sanofi - Aventis Groupe https://ift.tt/sEpaWC5
via IFTTT
Tags:
Nitesh sinha

Posted by: Nitesh sinha

Post a Comment

0 Comments

Please ,
Do not enter any kind of span link